Skip to main content
. 2017 Feb 20;474(5):699–713. doi: 10.1042/BCJ20160941

Table 1. Top hits from DSF screening.

Calbiochem collection Tm shift (°C) PKIS collection Tm shift (°C) Clinical inhibitors Tm shift (°C)
Cdk1/2 Inhibitor III 9.6 GW300657X 8.8 Rebastinib 12.6
Alsterpaullone, 2-Cyanoethyl 7.9 GW416981X 8.7 Dabrafenib 10.4
Indirubin E804 7.6 GW779439X 8.1 SNS-032 7.0
Cdk2/9 Inhibitor 7.2 GW300660X 6.8 Milciclib 6.2
Aurora/Cdk Inhibitor 6.7 GW301784X 6.0 AZ23 5.8
(Z,E)-3-(imidazol-4-ylmethylene)indolin-2-one 6.7 GSK238583A 5.8 AT9283 5.7
Indirubin-3′-monoxime-5-sulphonic acid 6.7 SB-732881-H 5.5 Ponatinib 5.5
Flt3 Inhib III 6.6 SB-739245-AC 5.4 Dinaciclib 4.8
5-Iodo-indirubin-3′-monoxime 6.1 SB-732881 5.2 PIK-75 4.7
SU9516 6.0 GW780056X 4.8 Regorafenib 4.1